Moneycontrol
Get App
SENSEX NIFTY
you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Feb 14, 16:00
333.65 6.00 (1.83%)
Volume
AVERAGE VOLUME
5-Day
57,613
10-Day
60,831
30-Day
61,936
104,393
  • Prev. Close

    327.65

  • Open Price

    330.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 14, 15:58
333.80 6.20 (1.89%)
Volume
AVERAGE VOLUME
5-Day
1,333,471
10-Day
1,341,959
30-Day
1,620,208
2,220,290
  • Prev. Close

    327.60

  • Open Price

    329.55

  • Bid Price (Qty.)

    333.80 (2770)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Profit & Loss account of Glenmark Pharma (in Rs. Cr.) Mar 19 Mar 18 Mar 17 Mar 16 Mar 15  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 9,705.08 8,972.23 8,970.09 7,457.92 6,595.26  
Less: Excise/Sevice Tax/Other Levies 0.00 28.65 106.27 87.91 0.00  
Revenue From Operations [Net] 9,705.08 8,943.58 8,863.82 7,370.01 6,595.26  
Total Operating Revenues 9,865.47 9,074.42 9,079.41 7,561.67 6,629.75  
Other Income 208.14 91.40 37.37 20.00 20.46  
Total Revenue 10,073.61 9,165.82 9,116.78 7,581.67 6,650.22  
EXPENSES  
Cost Of Materials Consumed 2,444.71 2,150.11 2,354.81 1,928.75 1,824.84  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Employee Benefit Expenses 2,056.07 1,871.84 1,640.81 1,378.20 1,202.41  
Finance Costs 334.59 285.57 237.32 178.89 188.72  
Depreciation And Amortisation Expenses 325.91 301.88 264.37 234.28 259.98  
Other Expenses 2,861.26 2,548.64 2,787.58 2,443.74 2,470.39  
Total Expenses 8,940.16 8,046.49 7,544.40 6,537.69 6,055.93  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,133.45 1,119.33 1,572.38 1,043.98 594.28  
Exceptional Items 167.18 0.00 -80.95 0.00 0.00  
Profit/Loss Before Tax 1,300.63 1,119.33 1,491.43 1,043.98 594.28  
Tax Expenses-Continued Operations  
Current Tax 476.54 325.69 619.04 511.44 365.01  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -100.91 -10.23 -236.37 -210.50 -245.97  
Other Direct Taxes 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 375.64 315.46 382.68 300.94 119.04  
Profit/Loss After Tax And Before ExtraOrdinary Items 924.99 803.87 1,108.75 743.05 475.24  
Profit/Loss From Continuing Operations 924.99 803.87 1,108.75 743.05 475.24  
Profit/Loss For The Period 924.99 803.87 1,108.75 743.05 475.24  
Minority Interest 0.00 0.00 0.00 0.00 0.07  
Consolidated Profit/Loss After MI And Associates 924.99 803.87 1,108.75 743.05 475.31  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 33.00 28.00 39.00 26.00 18.00  
Diluted EPS (Rs.) 33.00 28.00 39.00 26.00 18.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 68.03 67.92 67.95 67.92 0.00  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Source : Dion Global Solutions Limited